Artificial Intelligence Can’t Solve Cancer Unless It Gets The Right Data — Here’s How One Company Is Helping
$80M funding round closed for UPenn spinoff Vivodyne, which developed HIVE robotic labs to cultivate 20 kinds of human tissue for training AI algorithms to predict chemo response (with 94–100% accuracy)
A startup spun out from UPenn just raised $80M to build their HIVE robotic labs, which grow 20 different types of human tissues to teach AI models to forecast the efficacy of chemotherapy with up to 94–100% accuracy — twice as fast as the entire US animal testing industry combined!
Today, 90% of drugs that are effective in mice fail in humans because AI models are being trained on cells slices rather than live tissues. However, if we could train AI models using high-quality human data, pharmacology would become deterministic, and we could methodically search for a cure to cancer.
Source: techcrunch.com
Free course
Stop reading about AI — start building with it
The free Claude Code course: your first site, tool or game — no coding. No upsells, no cross-sells — nothing to buy here.
Start free →
Author
Evgenii Arsentev
PhD · Founder & CEO, Dad4Kids
Articles · Latest articles